Tiger

LendingClub stock jumped 26.5% in Tuesday after-hours trading after the online lender's Q2 EPS more than doubled the Wall Street estimate and its Q3 guidance indicates strong loan origination.The company expects Q3 loan originations of $2.5B-$2.6B, better than the Visible Alpha consensus of $2.4B. P...

China and the US will continue efforts to extend paused reciprocal tariffs, including the 24% portion suspended by the US, and China’s countermeasures as scheduled, according to Li Chenggang, a senior official from China’s Ministry of Commerce.Li said trade teams from China and the US engaged in in-...

Here Are the Biggest Calls on Wall Street on Tuesday:Goldman Sachs reiterates Microsoft as BuyBullish heading into Wednesday's earnings.“Microsoft is well-positioned to capitalize on this shift with a more capital-efficient and higher-margin recurring revenue model, just as it did during the on-prem...

Fannie Mae Rallies over 15% While Freddie Mac Jumps over 12%

Celestica raised its full-year revenue forecast for the third time in a row as demand grows for its cloud-computing segment. The shares jumped 18% on Tuesday.Cadence Design raised its annual sales and profit forecast, after the U.S. lifted export curbs on chip design software to China earlier this m...

U.S. stocks moved higher on the heels of some solid corporate earnings after the S&P 500 and Nasdaq Composite eked out yet another record even has trading remains restrained.This week is a key stretch for corporate earnings, with “Magnificent Seven” names Meta Platforms, Microsoft, Apple and Amazon ...

S&P 500 and Nasdaq futures ticked higher on Tuesday as investors assessed earnings reports from some of the top U.S. companies, while Dow futures lost some steam following a gloomy outlook from heavyweight UnitedHealth.Market SnapshotAt 8:15 a.m. ET, Dow e-minis were up 65 points, or 0.14%, S&P 500 ...

Crypto shares dropped. BitMine down 14%; GameSquare down 3%; SharpLink Down 2%; Bitfarms and IREN down 1%.

Crypto shares tumbled. Sequans down 23%; BitMine down 12%; SharpLink down 4%; Circle and Coinbase down 3%.

Unitedhealth Q2 Revenue $111.6 Billion

The stock market could keep rising to new heights this summer, at least until the big test of Nvidia ’s earnings due at the end of August, according to the JPMorgan trading desk. The Wall Street firm said it remains “tactically bullish” even after the 30% rebound in the S & P 500 off its low on Apri...

In a major win for Sarepta Therapeutics, US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again. The shares soared 44% in premarket trading.Celestica raised its full-year revenue forecast for the third time in a row as demand grows for its cloud-...

Chip stocks jumped in premarket trading. SOXL up over 2%; Nvidia, AMD, Super Micro up more than 1%; Marvell, Broadcom up within 1%.

Pop Mart Jumped 5% as JP Morgan says Don't Worry About Labubu's Search Popularity Dip, Look at Hello KittyJPMorgan believes that although Labubu's search popularity has declined by 5% from its peak, this is not a sign of its waning popularity, but rather a normal phenomenon in the development proces

HK pharma stocks shined. JWTherap up 25%; TigerMed up 9%; Microport up 5%; JunShi Bio and Zai Lab up 4%.

Crypto Daily is our column tracking crypto market trends, offering timely insights and valuable updates to keep you informed.Crypto NewsInteractive Brokers considers launching new stablecoin for customersInteractive Brokers Group is considering launching a stablecoin for customers, joining a number ...

SHANGHAI FUDAN surged 11%, with a year-to-date increase of over 116%! The company has commissioned Fudan University to develop super large-scale FPGA layout and routing technology.SHANGHAI FUDAN announced that on July 28, the company entered into a technology service contract with Fudan University. ...

HK stablecoin concept stocks dropped. Lianlian down 7%; CR Holdings and ZA Online down 6%; Linklogis and Bright Smart down 5%.

WUXI APPTEC surged 7% as the net profit for the first half of the year reached 8.561 billion RMB, marking a year-on-year growth of 101.92%. The company also raised its full-year sales forecast.

In a major win for Sarepta Therapeutics, US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again. The shares soared 47.2% in overnight trading.Celestica raised its full-year revenue forecast for the third time in a row as demand grows for its clou...